PubMed

A phase 1 trial of nebulised heparin in acute lung injury.

Dixon B, Santamaria JD, Campbell DJ.

Crit Care. 2008;12(3):R64. Epub 2008 May 6.PMID: 18460218 [PubMed - indexed for MEDLINE]Related articlesFree article

Elevated pulmonary dead space and coagulation abnormalities suggest lung microvascular thrombosis in patients undergoing cardiac surgery.

Dixon B, Campbell DJ, Santamaria JD.

Intensive Care Med. 2008 Jul;34(7):1216-23. Epub 2008 Feb 27.PMID: 18301879 [PubMed - indexed for MEDLINE]Related articles

Nebulised heparin: a new approach to the treatment of acute lung injury?

Suter PM.

Crit Care. 2008;12(4):170. Epub 2008 Jul 25.PMID: 18671836 [PubMed - indexed for MEDLINE]Related articlesFree article

Course of thrombin activation markers in patients implanted with Palmaz-Schatz stents: first experiences with a post-interventional anticoagulation regimen.

Haushofer A, Halbmayer WM, Dittel M, Prachar H, Mlczoch J, Fischer M.

Blood Coagul Fibrinolysis. 1994 Oct;5(5):697-706.PMID: 7865675 [PubMed - indexed for MEDLINE]Related articles

Anticoagulant therapy in acute lung injury.

Laterre PF, Wittebole X, Dhainaut JF.

Crit Care Med. 2003 Apr;31(4 Suppl):S329-36. Review.PMID: 12682461 [PubMed - indexed for MEDLINE]Related articles

A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin.

Levine MN, Hirsh J, Gent M, Turpie AG, Cruickshank M, Weitz J, Anderson D, Johnson M.

Arch Intern Med. 1994 Jan 10;154(1):49-56.PMID: 8267489 [PubMed - indexed for MEDLINE]Related articles

Anticoagulant effects and tissue factor pathway inhibitor after intrapulmonary low-molecular-weight heparin.

Harenberg J, Malsch R, Angelescu M, Lange C, Michaelis HC, Wolf H, Heene DL.

Blood Coagul Fibrinolysis. 1996 Jun;7(4):477-83.PMID: 8840001 [PubMed - indexed for MEDLINE]Related articles

Activated clotting time differential is a superior method of monitoring anticoagulation following coronary angioplasty.

Pitney MR, Kelly SA, Allan RM, Giles RW, McCredie M, Walsh WF.

Cathet Cardiovasc Diagn. 1996 Feb;37(2):145-50.PMID: 8808069 [PubMed - indexed for MEDLINE]Related articles

Heparin dosing and therapeutic activated partial thromboplastin times (aPTT) in acute coronary syndrome (ACS).

Westaway KP, Cruickshank M.

Aust Crit Care. 2006 Feb;19(1):6-8, 10-4.PMID: 16544673 [PubMed - indexed for MEDLINE]Related articles

Phase I trial of the recombinant soluble complement receptor 1 in acute lung injury and acute respiratory distress syndrome.

Zimmerman JL, Dellinger RP, Straube RC, Levin JL.

Crit Care Med. 2000 Sep;28(9):3149-54.PMID: 11008973 [PubMed - indexed for MEDLINE]Related articles

Endothelial cell activation and blood coagulation in critically ill patients with lung injury.

Wenzel C, Kofler J, Locker GJ, Laczika K, Quehenberger P, Frass M, Knöbl P.

Wien Klin Wochenschr. 2002 Oct 31;114(19-20):853-8.PMID: 12503477 [PubMed - indexed for MEDLINE]Related articles

Comparison of anticoagulant effects and safety of argatroban and heparin in healthy subjects.

Swan SK, St Peter JV, Lambrecht LJ, Hursting MJ.

Pharmacotherapy. 2000 Jul;20(7):756-70.PMID: 10907966 [PubMed - indexed for MEDLINE]Related articles

Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.

Raivio P, Kuitunen A, Petäjä J, Ilveskero S, Lassila R.

Thromb Haemost. 2008 Feb;99(2):427-34.PMID: 18278195 [PubMed - indexed for MEDLINE]Related articles

The activated clotting time can be used to monitor the low molecular weight heparin dalteparin after intravenous administration.

Marmur JD, Anand SX, Bagga RS, Fareed J, Pan CM, Sharma SK, Richard MF.

J Am Coll Cardiol. 2003 Feb 5;41(3):394-402.PMID: 12575965 [PubMed - indexed for MEDLINE]Related articles

Intravenous administration of activated protein C in Pseudomonas-induced lung injury: impact on lung fluid balance and the inflammatory response.

Robriquet L, Collet F, Tournoys A, Prangère T, Nevière R, Fourrier F, Guery BP.

Respir Res. 2006 Mar 22;7:41.PMID: 16553944 [PubMed - indexed for MEDLINE]Related articlesFree article

Activated partial thromboplastin time (aPTT) monitoring to achieve therapeutic anticoagulation before and after introducing a nomogram for adjunctive heparin treatment with thrombolytic therapy for acute myocardial infarction.

Chamuleau SA, de Winter RJ.

Int J Cardiol. 1998 Dec 31;67(3):241-6.PMID: 9894705 [PubMed - indexed for MEDLINE]Related articles

Dose-effect relationship for several coagulation markers during administration of the direct thrombin inhibitor S 18326 in healthy subjects.

Gaussem P, Dubar M, le Bonniec B, Richard-Lordereau I, Jochemsen R, Aiach M.

Br J Clin Pharmacol. 2002 Feb;53(2):147-54.PMID: 11851638 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of heparin loading during congenital heart operation on thrombin generation and blood loss.

Turner-Gomes SO, Nitschmann EP, Norman GR, Andrew ME, Williams WG.

Ann Thorac Surg. 1997 Feb;63(2):482-8.PMID: 9033324 [PubMed - indexed for MEDLINE]Related articles

Oral delivery of anticoagulant doses of heparin. A randomized, double-blind, controlled study in humans.

Baughman RA, Kapoor SC, Agarwal RK, Kisicki J, Catella-Lawson F, FitzGerald GA.

Circulation. 1998 Oct 20;98(16):1610-5.PMID: 9778325 [PubMed - indexed for MEDLINE]Related articlesFree article

Vascular endothelial injuries and changes of blood coagulation and fibrinolysis indexes in patients with acute respiratory distress syndrome.

He XL, Liu Z, Xia SY.

Chin Med Sci J. 2004 Dec;19(4):252-6.PMID: 15669181 [PubMed - indexed for MEDLINE]Related articles